4.3.3 Future Status of Blood Typing Reagent Market
Accompanied with further expansion of coverage of automated blood typing instrument market, promotion of newborn test, genotyping, and other new test items will also facilitate further expansion of blood typing reagent market. Enterprises in the industry shall meet clinical requirements, increase R&D inputs, continuously develop series test reagent products compatible with instruments, and provide all-round blood transfusion test solutions for clinical applications to meet use requirements of clinical units of different levels.
In recent years, the country has promulgated centralized bulk-buying policy for high value medical consumables in the field of medical devices. For instance, centralized procurement in the fields of chemiluminescent detection reagents for coronary stent, joint prosthesis, and chemiluminescence detection reagents for IVD and SARS-CoV-2 detection reagents have been conducted, while blood typing reagents have not been included in centralized procurement yet. Accompanied with gradual expansion of scope of centralized procurement, it is possible for blood typing reagents to be included in the scope of centralized procurement, and concentration ratio is expected to further increase by then. Enterprises in the industry of blood typing instruments and reagents shall seize opportunities, strengthen their technical innovations, use advanced diagnostic techniques to realize more efficient, precise and safe analysis and test, and offer more advanced products and better services for the field of blood typing to benefit the public.
Last: In Vitro Diagnostic Industry in China - Blood Typing Instruments and Reagents XV
